中文         Site Map |
 
 
 
Chairman of Guilin Pharma visited the Minister of Public Health of Cameroon
Date: Aug.13.2013
 

 
On 22nd July 2013, Mr Yu Zhemin, chairman of Guilin Pharmaceutical Co., Ltd. visited Dr. Andre MAMA FOUNDA, the minister of Public Health of Cameroon during his three day’s business trip to Yaounde, the Capital city of Cameroon.
 
On the meeting Mr.Yu briefly presented to Dr. Founda Guilin Pharma of its artimisinin based antimalaria products certificated by the World Health Organization, and Guilin’s business development in Cameroon. The minister highly appreciated the achievements Guilin achieved on antimalarials as a professional pharmaceutical manufacturer responsible for the quality of its products. He also agreed with Guilin’s efforts to continuously R&D to bring new products to the market. “In the past few years, the Chinese government have aided a huge number of high quality China made antimalaria drugs to Cameroon” commented by Dr. Founda, “among which  there are different artesunate based therapies from Guilin Pharma, which have helped to save thousands of lives of Cameroon people.”
Mr. Yu expressed his sincere thankfulness to the government of Cameroon for the appreciation of Guilin Pharma’s products, “in future”, said Mr. Yu, “We will continue to supply high quality pharmaceutical products to the people of Cameroon at affordable prices.”
 
Guilin Pharma had its core antimalaria product Artesun, successfully registered in Cameroon in April this year, and now started to market the drug in the whole country. One week after the product launch, Guilin pharmaceutical reached a cooperation agreement with the largest children's hospital in Yaounde on an Artesun experimental treatments to children with severe malaria. The study results and its experience will be introduced to all field healthcare staff of Cameroon so as to help to reduce the country’s malaria mortality.
      
Cameron has a national population of 20 million, of which 70% are at a high risk of malaria, while children under the age of 5 yea account for 90% of all malaria deaths. We believe the launch of Artesun in Cameroon will bring a better treatment for severe malaria, and help to save more lives of its children.
 

This site is published by Guilin Pharmaceutical (Shanghai) Corporation,        which is solely responsible for its content. All rights reserved.

© Guilin Pharmaceutical (Shanghai) Co., Ltd. 2017.